CH394235A - Procédé de préparation de l'iodhydrate de lysine - Google Patents
Procédé de préparation de l'iodhydrate de lysineInfo
- Publication number
- CH394235A CH394235A CH884261A CH884261A CH394235A CH 394235 A CH394235 A CH 394235A CH 884261 A CH884261 A CH 884261A CH 884261 A CH884261 A CH 884261A CH 394235 A CH394235 A CH 394235A
- Authority
- CH
- Switzerland
- Prior art keywords
- lysine hydrochloride
- lysine
- solution
- sub
- reaction
- Prior art date
Links
- 229960005337 lysine hydrochloride Drugs 0.000 title claims description 18
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 title claims description 17
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title description 3
- 239000004472 Lysine Substances 0.000 claims description 5
- 229960003646 lysine Drugs 0.000 claims description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 239000000376 reactant Substances 0.000 claims description 2
- 239000012429 reaction media Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 2
- 229910001651 emery Inorganic materials 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940071870 hydroiodic acid Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- SBZKOWAPPRXYGA-XRIGFGBMSA-N (2s)-2,6-diaminohexanoic acid;dihydrate Chemical compound O.O.NCCCC[C@H](N)C(O)=O SBZKOWAPPRXYGA-XRIGFGBMSA-N 0.000 description 1
- QLOKJRIVRGCVIM-UHFFFAOYSA-N 1-[(4-methylsulfanylphenyl)methyl]piperazine Chemical compound C1=CC(SC)=CC=C1CN1CCNCC1 QLOKJRIVRGCVIM-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 231100000668 minimum lethal dose Toxicity 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Polyamides (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR834516A FR81M (enEXAMPLES) | 1960-07-29 | 1960-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH394235A true CH394235A (fr) | 1965-06-30 |
Family
ID=8736585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH884261A CH394235A (fr) | 1960-07-29 | 1961-07-27 | Procédé de préparation de l'iodhydrate de lysine |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE606635A (enEXAMPLES) |
| CH (1) | CH394235A (enEXAMPLES) |
| ES (1) | ES269439A1 (enEXAMPLES) |
| FR (1) | FR81M (enEXAMPLES) |
-
1960
- 1960-07-29 FR FR834516A patent/FR81M/fr active Active
-
1961
- 1961-07-27 CH CH884261A patent/CH394235A/fr unknown
- 1961-07-27 BE BE606635A patent/BE606635A/fr unknown
- 1961-07-28 ES ES0269439A patent/ES269439A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES269439A1 (es) | 1962-01-01 |
| FR81M (enEXAMPLES) | 1961-01-09 |
| BE606635A (fr) | 1961-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001520670A (ja) | 芳香族及び複素環の硝酸誘導体 | |
| FR2696740A1 (fr) | Dérivés prodrogués de la diméthylbiguanide et applications comme médicaments. | |
| CH394235A (fr) | Procédé de préparation de l'iodhydrate de lysine | |
| CA1312333C (fr) | Sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant | |
| CH394199A (fr) | Procédé de préparation de nicotinate de lysine | |
| CA2182112A1 (fr) | Derives de n,n'-di(aralkyl) n,n'-di(carboxyalkyl) alkylene di- ou triamine et de n-(aralkyl) n'-(carboxyalkyl) n,n'-di(carboxyalkyl) alkylene di- ou triamine et leur utilisation en pharmacie et en cosmetique | |
| CH394236A (fr) | Procédé de préparation de l'iodhydrate de lysine | |
| US3870792A (en) | Certain dihydrophthalizines for treating hemorrhage and thrombosis | |
| WO1981002295A1 (fr) | Phenoxyisobutyrates de moroxydine et medicaments les contenant | |
| CA1140155A (fr) | PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE DU 1.alpha.,25-DIHYDROXY CHOLECALCIFEROL | |
| US3592852A (en) | Substituted benzylideneamino guanidine | |
| US6060498A (en) | Composition containing antitumor agent | |
| CH639083A5 (fr) | Procede de preparation d'un acide chromone carboxylique. | |
| US3652582A (en) | Adduct of 5 5-dimethylhydantoin with chloral hydrate and its preparation | |
| CH394231A (fr) | Procédé de préparation d'acétyl-tryptophanate d'amphétamine | |
| WO1998017673A1 (en) | Isosorbide aspirinate esters | |
| US4120958A (en) | Novel 2-acetoxybenzoic acid-nicotinamide complexes | |
| EP0070049B1 (fr) | Dérivé de l'acide acétylsalicylique ayant activité analgésique, antipyrétique, antiphlogistique et bronchosécrétolytique | |
| CA1048061A (en) | Process for the preparation of a therapeutically active dihalogenoaminobenzylamine | |
| CH665634A5 (en) | Stable soluble catechin complexes - with a double salt of L-lysine, for liver protection and digestive ulcers | |
| US3317391A (en) | Composition for treatment of angina pectoris and process for preparing same | |
| CA1189526A (fr) | Procede de preparation de nouveaux derives amines de l'acide 4-phenyl 4-oxo 2-butenoique et de leurs sels | |
| KR820001122B1 (ko) | N-알케닐 몰라노린 유도체의 제조방법 | |
| LU83440A1 (fr) | N-oxyde de 4-methoxy-n-(2-(2-(1-methyl-2-piperidyl)ethyl)phenyl)benzamide et son procede de preparation | |
| CA2193096C (fr) | Derives de l'acide guanylique et applications comme medicaments |